Product Explainer

Vaginal micronised progesterone soft gel capsule for the treatment of threatened miscarriage

Description

In this Product Explainer, Professor of Obstetrics & Gynaecology, William Ledger explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone

Prof Andrew Sindone

Heart Failure – Demystifying Pharmacological Management for GPs

Dr Rupert Hinds

Dr Rupert Hinds

Iron Deficiency in Children & Young People

Speaker TBA

Speaker TBA

Heart Failure – Assessment and Monitoring in Primary Care

Prof Dave Singh

Prof Dave Singh

COPD Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof William Ledger

expert

Prof William Ledger

Gynaecologist; Royal Hospital for Women, UNSW

Date published: 8 August 2023